Big Biogen boost on Alzheimer’s news could
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to
U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to
Urban Indians are getting COVID-19 shots much faster than the hundreds of millions of
AstraZeneca (AZN.L) will move finance chief Marc Dunoyer to head newly acquired rare diseases
Erik Prince, the founder of controversial private military firm Blackwater and a supporter of
Here's what you need to know about the coronavirus right now.
Coronavirus variants with clunky, alphanumeric names have now been assigned the letters of the
Australia’s second-most populous state of Victoria, the epicentre of the country’s latest coronavirus hotspot,
Breathless, fevered and without the extra oxygen that could help keep them alive, the
Here's what you need to know about the coronavirus right now.